Abstract
Glutaric aciduria type i is a disorder resulting trom the deficiency ot the glutaryl-CoA dehydrogenase, enzyme involved in the catabolism ot L-lysine, L-hydroxy-lysine y L-tryptophan causing the accumulation ot its derivatives glutaric acid and 3-hydroxy-glutaric acid which are responsible tor the severe neurological involvement observed in this disease. The diagnosis ot metabolic disorders represents a challenge tor health-care services given its low incidence. Glutaric aciduria type I is a disease tor which there are available technical resources tor diagnosis as well as the nutritional therapy that when set prior to acute encephalopathy, who results in irreversible damage ot central nervous system, can improve the prognosis and decrease the disability ot patients. This publication report 5 cases with clinical and biochemical diagnosis ot glutaric aciduria type i that show the clinical spectrum the diagnostic and treatment approach ot this pathology in Colombia. All the patients are being followed by neuropediatrics services.
References
LINDNER M, KÖLKER S, SCHULZE A, CHRISTENSEN E, GREENBERG CR, HOFFMANN GF. Neonatal Screening for glutaryl-CoA dehydrogenase deficiency. J Inherited Metab Dis 2004;27:851-9.
FU Z, WANG M, PASCHKE R, RAO KS, FRERMAN FE, KIM JJ. Crystal structures of human glutaryl-CoA dehydrogenase with and without an alternate substrate: structural bases of dehydrogenation and decarboxilation reactions. Biochemistry 2004;43:9674-84.
ZSCOCKE J, QUAK E, GULDBERG P. Mutation analysis in glutaric aciduria type I. J Med Genet 2000;37:177-81.
STRAUSS KA, MORTON DH. Type I glutaric aciduria, part 2: A model of acute striatal necrosis. Am J Med Genet Semin Med Genet 2003;121c:53-70.
KÖLKER S, GARBADE SF, GREENBERG CR, LEONARD JV, SAUDUBRAY JM, RIBES A, ET AL. Natural History, outcome and treatment efficacy in children and adults with glutaryl-coa dehydrogenasa deficiency. Pediatr res 2003;59:840-47.
STRAUSS KA, MORTON DH. Type I glutaric aciduria, part 2: A model of acute striatal necrosis. Am J Med Genet Semin Med Genet 2003;121c:53-70.
LINDNER M, HO S, FANG-HOFFMANN J, HOFFMANN GF, KÖLKER S. Neonatal Screening for glutaric aciduria type I: strategies to proceed. J Inheri Metab Dis 2006;29:378-82.
BARIC I, WAGNER L, FEYH P, LIESERT M, BUCKEL W, HOFFMANN GF. Sensitivity of free and total glutaric and 3 hidroxyglutaric acid measurement by stable isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis 1999;22:867-82.
KÖLKER S, CHRISTENSEN E, LEONARD JV, GREENBERG CR, BURLINA AB, BURLINA AP, ET AL. Guideline for the diagnosis and management of glutaryl -CoA dehydrogenase deficiency (Glutaric Aciduria Type I). J Inherited Metab Dis 2007;30:5-22.
KÖLKER S, CHRISTENSEN E, LEONARD JV, GREENBERG CR, BONEH A, BURLINA AB, ET AL. Diagnosis and management of glutaric type I - revised recommendations. J Inherit Metab Dis 2011;34:677-94.
TWOMEY EL, NAUGHTEN ER, DONOGHUE VB, RYAN S. Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 2003;33:823-30.
COUCE-PICO ML, CASTIÑEIRAS-RAMOS DE, LÓPEZ-SOUSA M, FERNÁNDEZ-SEARA MJ, EIRÍS-PUÑAL J, COCHO-DE-JUAN JA. Importance of early diagnosis and treatment in the prognosis of type I Glutaric Acidaemia. An Pediatr (Bare) 2008;69:239-43.
BIJARNIA S, WILEY V, CARPENTER K, CHRISTODOULOU J, ELLAWAY CJ, WILCKEN B. Glutaric Aciduria type I. Outcome following detection by newborn screening. J InheritMetab 2008;31:503-7.
BJUGSTAD KB, GOODMAN SI, FRED CR. Age at symptom onset predicts severity of motor impairment and clinical onset of glutaric aciduria type I. J Pediatr 2000;137: 861-86.
HERINGER J, BOY SP, ENSENAUER R, ASSMANN B, ZSCHOCKE J, HARTING I, LÜCKE T, ET AL. Use of guidelines improves the neurological outcome in glutaric aciduira type I. Ann Neurol 2010;68:743-52.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.